Piper Sandler raises Corcept Therapeutics target price to $173 from $165
CORT•Piper Sandler raised its target price for Corcept Therapeutics to $173 from $165.
Related News
BioMarin Pharmaceutical Inc.: JP Morgan cuts target price to $86 from $87
BMRN•
Amdocs management commentary on Q4 FY2026: Restructuring charge weighs on GAAP EPS
DOX•
Scotiabank raises Block target price to $89 from $82
XYZ•
ADM: JP Morgan raises to neutral from underweight
ADM•
Coastal Financial Corp (Everett): Stephens raises target price to $60 from $54
CCB•